UBS Group’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $324K | Buy |
|
|||||
|
2024
Q4 | $142K | Buy |
|
|||||
|
2024
Q3 | $46.9K | Buy |
|
|||||
|
2024
Q2 | $34.3K | Buy |
|
|||||
|
2024
Q1 | $870 | Sell |
|
|||||
|
2023
Q4 | $440 | Sell |
|
|||||
|
2023
Q3 | $558 | Sell |
|
|||||
|
2023
Q2 | $5.31K | Buy |
|
|||||
|
2023
Q1 | $1.47K | Sell |
|
|||||
|
2022
Q4 | $7.76K | Sell |
|
|||||
|
2022
Q3 | $17K | Buy |
|
|||||
|
2022
Q2 | $17K | Buy |
|
|||||
|
2022
Q1 | $18K | Buy |
|
|||||
|
2021
Q4 | $8K | Buy |
|
|||||
|
2021
Q3 | $14K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $4K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $7K | Sell |
|
|||||
|
2019
Q3 | $12K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2K | Buy |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $3K | Buy |
|
|||||
|
2018
Q2 | $10K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $19K | Buy |
|
|||||
|
2017
Q3 | $0 | Sell |
|
|||||
|
2017
Q2 | $31K | Sell |
|
|||||
|
2017
Q1 | $61K | Buy |
|
|||||
|
2016
Q4 | $78K | Buy |
|
|||||
|
2016
Q3 | $86K | Sell |
|
|||||
|
2016
Q2 | $92K | Buy |
|
|||||
|
2016
Q1 | $214K | Buy |
|
|||||
|
2015
Q4 | $127K | Buy |
|
|||||
|
2015
Q3 | $64K | Buy |
|
|||||
|
2015
Q2 | $88K | Buy |
|
|||||
|
2015
Q1 | $112K | Buy |
|
|||||
|
2014
Q4 | $16K | Buy |
|